Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) commonly used in compounded formulations to manage pain and inflammation associated with various conditions. It works by inhibiting the enzymes COX-1 and COX-2, which play a crucial role in the synthesis of prostaglandins, compounds that mediate inflammation and pain in the body.

Due to its selective inhibition of COX-2, meloxicam is often preferred for its reduced gastrointestinal side effects compared to other NSAIDs. This makes it a valuable option for patients requiring long-term management of chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis.

In a compounding pharmacy setting, meloxicam can be tailored into various dosage forms to meet specific patient needs, enhancing compliance and therapeutic outcomes. Its pharmacokinetic profile allows for once-daily dosing, which is convenient for patients and helps maintain consistent therapeutic levels.

Prescribers should consider patient-specific factors such as renal function, cardiovascular risk, and gastrointestinal history when recommending meloxicam. This ensures optimal safety and efficacy, particularly in populations that may be more susceptible to NSAID-related adverse effects.